Savara's Grant - IV Round

Savara raised a round of funding on April 20, 2012. Investors include National Institutes of Health.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…

Articles about Savara's Grant - IV Round: